PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer

VK Tishchenko, VM Petriev, OP Vlasova… - Physics of Atomic …, 2022 - Springer
Molecular changes in prostate cancer lead to increased expression of prostate-specific
membrane antigen (PSMA), which is a suitable target for imaging and therapy using …
被引用次数：1 相关文章

[引用][C] PSMA-TARGETED RADIOPHARMACEUTICALS FOR IMAGING AND THERAPY OF PROSTATE CANCER

VK Tishchenko, VM Petriev, VV Krylov, PV Shegai… - 2021 - elibrary.ru

PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer

VK Tishchenko, VM Petriev, OP Vlasova… - Physics of Atomic …, 2022 - ui.adsabs.harvard.edu
Molecular changes in prostate cancer lead to increased expression of prostate-specific
membrane antigen (PSMA), which is a suitable target for imaging and therapy using …

PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer.

VK Tishchenko, VM Petriev, OP Vlasova… - Physics of Atomic …, 2022 - search.ebscohost.com
Molecular changes in prostate cancer lead to increased expression of prostate-specific
membrane antigen (PSMA), which is a suitable target for imaging and therapy using …
[PDF] researchgate.net

[PDF][PDF] PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer

VK Tishchenkoa, VM Petrieva… - … OF ATOMIC NUCLEI, 2022 - researchgate.net
Molecular changes in prostate cancer lead to increased expression of prostate-specific
membrane antigen (PSMA), which is a suitable target for imaging and therapy using …